Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease

por Kumar, Anand, Kim, Emilie S, Kozan, Philip, Jacob, Vinita, Longman, Randy S, Scherl, Ellen J, Battat, Robert J, Lukin, Dana J
Publicado 2020

Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction

por Kozan, Philip A., McGeough, Matthew D., Peña, Carla A., Mueller, James L., Barrett, Kim E., Marchelletta, Ronald R., Sivagnanam, Mamata
Publicado 2014

The effect of a fennel seed extract on the STAT signaling and intestinal barrier function

por Das, Barun, Rabalais, John, Kozan, Philip, Lu, Tina, Durali, Nassim, Okamoto, Kevin, McGeough, Matthew D., Lee, Beom Jae, Barrett, Kim E., Marchelletta, Ronald, Sivagnanam, Mamata
Publicado 2022